Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Vitara RX vs Society of You

Two GLP-1 deals, scored on the same six factors. Vitara RX lands a Value Score of 91, Society of You a 65. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Vitara RX

#4 · Grade A · Best Value

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full Vitara RX review →
VS

Society of You

#317 · Grade C · Watch List

Est. first month

From $279/mo (compounded)

Save ~79% vs brand-name
Get this deal Full Society of You review →

The verdict

Better value: Vitara RX

Vitara RX takes it on Value Score, 91 to 65 an est. $99/mo first month, with no teaser step-up baked in. Society of You isn't out of it: Shoppers who want compounded GLP-1 from named partner pharmacies, including oral tirzepatide.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealVitara RXSociety of You
Value Score91 (A)65 (C)
Est. first month$99/moFrom $279/mo (compounded)
Save vs brand-name~93%~79%
Semaglutide$99/moFrom $279/mo (compounded)
Tirzepatide$149/moFrom $379/mo (compounded oral)
Both moleculesYesYes
PricingFlat — no step-upWatch
Coverage49 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

96
Lowest Real Price
56
Vitara RX: 96. Society of You: 56.
90
No Teaser-Rate Bait
72
Vitara RX: 90. Society of You: 72.
88
Nationwide Availability
45
Vitara RX: 88. Society of You: 45.
92
Both Molecules
98
Vitara RX: 92. Society of You: 98.
95
Easy Cancellation
58
Vitara RX: 95. Society of You: 58.
67
Reputation
70
Vitara RX: 67. Society of You: 70.

Vitara RX

VitaraRx is a direct-to-consumer telehealth marketplace offering compounded semaglutide and tirzepatide at flat per-drug pricing across all doses — no membership or hidden fees.

Why it's a deal

  • Among the lowest flat pricing in the market — $99/mo semaglutide and $149/mo tirzepatide, all doses same price
  • Names its 503A pharmacy partner (Manifest Pharmacy, Greer SC) — strong supply-chain transparency
  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer
  • Covers 49 states with an explicit state list, not vague "most states" language

The fine print

  • No corporate legal entity disclosed — only the trade name "VitaraRx"
  • No named medical director — all clinical decisions made by independent providers (marketplace model)
  • All sales final — no medication returns
  • Per-vial mg quantity isn't clearly disclosed, making price comparisons harder
  • Doesn't ship to Alaska

Society of You

Society of You is a US telehealth brand (Society Management Group) offering compounded GLP-1 weight-loss medication filled through named partner pharmacies (Emerald and Striker).

Why it's a deal

  • Two named partner pharmacies disclosed (Emerald Pharmacy, Striker Pharmacy)
  • Injectable and oral tirzepatide plus semaglutide options
  • Discounted first-month introductory pricing

The fine print

  • Standard rates are high once the intro month ends ($279-$425/mo)
  • Service-area states are not published on the marketing site
  • Support details are not disclosed publicly
Get the Vitara RX deal Get the Society of You deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Vitara RX is ranked on the Vitara RX alternatives board, and the same list for the other side is on alternatives to Society of You.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.